Compounds > plerixafor
Page last updated: 2024-08-24

plerixafor and Pneumonia

plerixafor has been researched along with Pneumonia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braun, S; Konrad, FM; Ngamsri, KC; Reutershan, J; Vollmer, I1
Bunjhoo, H; Cao, Y; Chen, H; Cheng, S; Liu, J; Teng, J; Wang, C; Xie, J; Xiong, W; Xu, X; Xu, Y1
Arimura, K; Higashimoto, I; Matsuyama, W; Mitsuyama, H; Noma, S; Oonakahara, K; Osame, M; Shirahama, Y; Watanabe, M1
Berlin, A; Bridger, GJ; Lukacs, NW; Schols, D; Skerlj, RT1

Other Studies

4 other study(ies) available for plerixafor and Pneumonia

ArticleYear
Heme oxygenase-1 attenuates acute pulmonary inflammation by decreasing the release of segmented neutrophils from the bone marrow.
    American journal of physiology. Lung cellular and molecular physiology, 2014, Nov-01, Volume: 307, Issue:9

    Topics: Acute Disease; Administration, Inhalation; Animals; Benzylamines; Bone Marrow Cells; Bronchoalveolar Lavage Fluid; Chemokine CXCL12; Cyclams; Gene Expression Regulation; Heme Oxygenase-1; Heterocyclic Compounds; Immunity, Innate; Lipopolysaccharides; Male; Membrane Proteins; Metalloporphyrins; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Neutrophils; Pneumonia; Protoporphyrins; Respiratory Burst

2014
CXCR4 inhibitor attenuates allergen-induced lung inflammation by down-regulating MMP-9 and ERK1/2.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:6

    Topics: Allergens; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Benzylamines; Bronchi; Cell Line; Chemokine CXCL12; Cyclams; Disease Models, Animal; Down-Regulation; Enzyme Activation; Epithelial Cells; Female; Heterocyclic Compounds; Humans; Interleukin-13; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Ovalbumin; Pneumonia; Receptors, CXCR4; Signal Transduction; Time Factors

2015
Dual effect of AMD3100, a CXCR4 antagonist, on bleomycin-induced lung inflammation.
    Journal of immunology (Baltimore, Md. : 1950), 2007, May-01, Volume: 178, Issue:9

    Topics: Animals; Anti-HIV Agents; Benzylamines; Bleomycin; Bronchoalveolar Lavage Fluid; Butadienes; Cyclams; Cytokines; Female; Heterocyclic Compounds; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neutrophils; Nitriles; Pneumonia; Pulmonary Fibrosis; Receptors, CXCR4

2007
AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity.
    The American journal of pathology, 2002, Volume: 160, Issue:4

    Topics: Allergens; Animals; Benzylamines; Bronchial Hyperreactivity; Cell Movement; Chemokines; Cyclams; Cytokines; Female; Heterocyclic Compounds; Hypersensitivity; Leukocytes; Mice; Mice, Inbred CBA; Pneumonia; Receptors, CXCR4

2002